Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has metastasized to his bones. This development raised concerns over why the condition wasn’t detected earlier, despite routine health evaluations typically conducted for presidents. Experts state that while Biden’s cancer is treatable, it is no longer curable, particularly with a high Gleason score indicating the severity of the disease.
White House Press Secretary Karoline Leavitt affirmed that President Donald Trump has confidence in the medical care provided, trusting his physicians. Radiation oncologist Dr. Curtiland Deville expressed concerns during a CNN segment, emphasizing the importance of early detection for better outcomes. Regular screenings, including PSA (prostate-specific antigen) tests, are crucial in identifying potential issues, but such tests have limitations in sensitivity.
Biden had a routine physical in February 2024, which described him as “healthy” for his age, noting stable management of other medical conditions. It raises questions about whether Biden was undergoing recommended screenings, particularly as guidelines suggest that men over 70, without significant risk factors, might stop such screenings. Experts like Dr. Otis Brawley have called for improved prostate cancer tests, highlighting the inadequacies of current screening methods.
While the current White House medical team, based at Walter Reed Medical Center, is regarded as exceptional, the diagnosis invites further scrutiny into cancer detection protocols. Biden’s situation serves as a chagrin reminder of the complexities surrounding cancer diagnosis and treatment, particularly as it pertains to early intervention and ongoing medical assessments.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
